Abdul Salam Vahitha

Dr. Abdul Salam Vahitha is a Senior Lecturer and Deputy Dean for Global Engagement & Partnerships at Queen Mary University of London's Faculty of Medicine and Dentistry. She leads the Vascular Pharmacology research group at the William Harvey Research Institute, focusing on vascular dysfunction mechanisms and translational drug discovery. Her roles include editorial board memberships at Frontiers in Cardiovascular Medicine and teaching drug design modules for undergraduate and postgraduate students.

Education: BPharm (First Class Honors, National University of Malaysia), PhD (Imperial College London). Awards include the Pfizer European Young Investigator Award (2011) and Barts Charity Rising Stars Lectureship (2020). Her research integrates proteomics, AI, and environmental health studies to address cardiovascular diseases, microplastic impacts, and pulmonary hypertension.

• Key Research Themes:
  • CLIC proteins in vascular remodeling
  • Proteomics-based biomarker discovery
  • AI-driven drug development
  • Microplastics' cardiovascular risks
• Collaborations: Imperial College London, Karolinska Institute, Water Research Centre Ltd
• Grants: Barts Charity, Innovate UK, Alan Turing Institute

Her lab investigates CLIC proteins' roles in diseases like PAH and atherosclerosis while developing targeted therapies. She also explores environmental pollutants' effects on vascular health, contributing to public health strategies.